基于DNase的治疗方法用于治疗与NETosis相关的炎症性疾病
Rachana Yadav1, Alfiya Momin1, Chandraiah Godugu1
1Department of Biological Sciences (Regulatory Toxicology), National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana, India.
International immunopharmacology
|August 27, 2023
概括
中性细胞细胞外陷 (NETs) 在NETosis期间释放以对抗病原体. 然而,过量的NET可以引起炎症,因此需要使用纳米技术等管理策略来治疗DNase酶.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 中性粒细胞是关键的先天性免疫细胞. NETosis涉及释放由DNA,基因组和颗粒蛋白组成的中性粒细胞外陷 (NETs).
- 丁氨酸减小酶-4 (PAD-4) 通过脱凝染色素来驱动NETosis. DNase酶可以分解NETs.
- 虽然生理性NET可以对抗感染,但过度的NET可以导致组织损伤和炎症,如果DNase.未被清除,则会导致DNase.
研究的目的:
- 为了审查NETosis的机制.
- 讨论NETs在炎症性疾病中的作用.
- 突出DNase的功能和潜在的基于纳米技术的NETosis相关炎症的管理策略.
主要方法:
- 关于NETosis机制的文献综述.
- 在NET分解中分析DNase酶功能的分析.
- 在管理NETosis中探索纳米技术应用.
主要成果:
- 网症是一种关键的先天性免疫过程,但如果失调,可能导致病理.
- 在NET降解和潜在的组织保护中,DNase起着双重作用.
- 异常高的NET度与炎症和组织损伤相关.
结论:
- 了解NETosis机制对于炎症疾病研究至关重要.
- DNase酶活性对于解决NET和防止自我损伤至关重要.
- 新的方法,包括纳米技术,为管理有害的NETosis效应提供了潜力.
更多相关视频
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
198
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
198
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
173
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
173
Inflammatory Response
2.1K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.1K
Skeletal Muscle Relaxants: Therapeutic Uses
511
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
511
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
703
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
703


